Published 25th November 2016

Anker Lundemose interviewed by Edison

Dr Anker Lundemose, CEO of portfolio company MISSION Therapeutics, was interviewed by Edison, the investment intelligence firm.

In the video series below, John speaks about the strength in MISSION's management team, the technology underlying the company's unique offering, and future pipeline developments.